» Articles » PMID: 35409644

Cardio-Pulmonary Dysfunction Evaluation in Patients with Persistent Post-COVID-19 Headache

Abstract

Background (1): Headache is a prevalent symptom experienced during ongoing SARS-CoV-2 infection, but also weeks after recovery. Whether cardio-pulmonary dysfunction contributes causally to headache persistence is unknown. Methods (2): We conducted a case-control analysis nested in a prospective cohort study. Individuals were recruited from August 2020 to December 2020. Patients were grouped according to the presence or absence of long-COVID headache for three months after COVID-19 resolution. We compared demographic data, clinical variables, cardio-pulmonary laboratory biomarkers, quality of life, and cardio-pulmonary function between groups. Results (3): A cohort of 70 COVID-19 patients was evaluated. Patients with headaches (n = 10; 14.3%) were more frequently female (100% vs. 58.4%; = 0.011) and younger (46.9 ± 8.45 vs. 56.13 ± 12 years; = 0.023). No between-group differences in laboratory analysis, resting echocardiography, cardio-pulmonary exercise test, or pulmonary function tests were observed. Conclusion (4): In this exploratory study, no significant differences in cardio-pulmonary dysfunction were observed between patients with and without long-COVID headache during mid-term follow-up.

Citing Articles

Prevalence and Risk Factors of Headache Associated with COVID-19.

Duranikova O, Horvathova S, Sabaka P, Minar M, Bolekova V, Straka I J Clin Med. 2024; 13(17).

PMID: 39274228 PMC: 11396359. DOI: 10.3390/jcm13175013.


Health equity, care access and quality in headache - part 1.

Tana C, Raffaelli B, Portes Souza M, Ruiz de la Torre E, Massi D, Kisani N J Headache Pain. 2024; 25(1):12.

PMID: 38281917 PMC: 10823691. DOI: 10.1186/s10194-024-01712-7.


Memory, Emotion, and Quality of Life in Patients with Long COVID-19.

Espinar-Herranz K, Delgado-Lima A, Villatoro B, Garaboa E, Gomez V, Vides L Brain Sci. 2023; 13(12).

PMID: 38137118 PMC: 10742100. DOI: 10.3390/brainsci13121670.


Manifestation of Headache Affecting Quality of Life in Long COVID Patients.

Fujita K, Otsuka Y, Sunada N, Honda H, Tokumasu K, Nakano Y J Clin Med. 2023; 12(10).

PMID: 37240639 PMC: 10219375. DOI: 10.3390/jcm12103533.


Biomarkers in long COVID-19: A systematic review.

Lai Y, Liu S, Manachevakul S, Lee T, Kuo C, Bello D Front Med (Lausanne). 2023; 10:1085988.

PMID: 36744129 PMC: 9895110. DOI: 10.3389/fmed.2023.1085988.


References
1.
. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38(1):1-211. DOI: 10.1177/0333102417738202. View

2.
Wei J, Wang H . Cardiac cephalalgia: case reports and review. Cephalalgia. 2008; 28(8):892-6. DOI: 10.1111/j.1468-2982.2008.01590.x. View

3.
Gonzalez-Martinez A, Fanjul V, Ramos C, Serrano Ballesteros J, Bustamante M, Villa Marti A . Headache during SARS-CoV-2 infection as an early symptom associated with a more benign course of disease: a case-control study. Eur J Neurol. 2021; 28(10):3426-3436. DOI: 10.1111/ene.14718. View

4.
Spuntarelli V, Luciani M, Bentivegna E, Marini V, Falangone F, Conforti G . COVID-19: is it just a lung disease? A case-based review. SN Compr Clin Med. 2020; 2(9):1401-1406. PMC: 7386162. DOI: 10.1007/s42399-020-00418-6. View

5.
Motiejunaite J, Balagny P, Arnoult F, Mangin L, Bancal C, dOrtho M . Hyperventilation: A Possible Explanation for Long-Lasting Exercise Intolerance in Mild COVID-19 Survivors?. Front Physiol. 2021; 11:614590. PMC: 7849606. DOI: 10.3389/fphys.2020.614590. View